New dialysis fluid aims to reduce sugar burden for kidney patients
Disease control
Recruiting now
This study is testing whether a new, low-glucose dialysis solution called XyloCore is as effective and safe as standard glucose-based solutions for people with end-stage kidney disease. About 170 patients who perform daily peritoneal dialysis at home will use either the new solut…
Phase: PHASE3 • Sponsor: Iperboreal Pharma Srl • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC